Replication stress is a cancer-specific vulnerability that can be exploited through inhibition of S-phase checkpoint kinases such as ATR and CHK1 among other therapeutic agents that can enhance replication stress and push cancer cells toward mitotic catastrophe [57]. Here, CHEK1 is linked to cancer.